Identification of 2 hypothetical genes involved in Neisseria meningitidis cathelicidin resistance.

Cathelicidins play a pivotal role in innate immunity, providing a first barrier against bacterial infections at both mucosal and systemic sites. In this work, we have investigated the mechanisms by which Neisseria meningitidis serogroup B (MenB) survives at the physiological concentrations of human and mouse cathelicidin LL37 and CRAMP, respectively. By analyzing the global transcription profile of MenB in the presence or absence of CRAMP, 21 genes were found to be differentially expressed. Among these genes, the hypothetical genes NMB0741 and NMB1828 were up-regulated. When either of the 2 genes was deleted, MenB resistance to cathelicidins was impaired in vitro. Furthermore, the deletion of either of the 2 genes substantially reduced MenB virulence, as measured by the number of bacteria found in the blood of infected animals. Altogether, these results indicate that NMB0741 and NMB1828 are novel genes that have never been described before and that are involved in MenB cathelicidin resistance.

[1]  T. Hökfelt,et al.  Induction of the Antimicrobial Peptide CRAMP in the Blood-Brain Barrier and Meninges after Meningococcal Infection , 2006, Infection and Immunity.

[2]  R. Hancock,et al.  Cationic host defense (antimicrobial) peptides. , 2006, Current opinion in immunology.

[3]  W. Shafer,et al.  Cationic Antimicrobial Peptide Resistance in Neisseria meningitidis , 2005, Journal of bacteriology.

[4]  Raquel Tobes,et al.  The TetR Family of Transcriptional Repressors , 2005, Microbiology and Molecular Biology Reviews.

[5]  D. Davidson,et al.  Impact of LL‐37 on anti‐infective immunity , 2005, Journal of leukocyte biology.

[6]  S. Funnell,et al.  Experimental disease models for the assessment of meningococcal vaccines. , 2005, Vaccine.

[7]  S. Falkow,et al.  Mig‐14 is an inner membrane‐associated protein that promotes Salmonella typhimurium resistance to CRAMP, survival within activated macrophages and persistent infection , 2004, Molecular microbiology.

[8]  S. Agarwal,et al.  Characterization of a novel Neisseria meningitidis Fur and iron‐regulated operon required for protection from oxidative stress: utility of DNA microarray in the assignment of the biological role of hypothetical genes , 2004, Molecular microbiology.

[9]  B. Finlay,et al.  Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[10]  W. Shafer,et al.  A Mutant Form of the Neisseria gonorrhoeae Pilus Secretin Protein PilQ Allows Increased Entry of Heme and Antimicrobial Compounds , 2004, Journal of bacteriology.

[11]  H. Tettelin,et al.  Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays , 2002, Nature Biotechnology.

[12]  A. Deghmane,et al.  The duality of virulence and transmissibility in Neisseria meningitidis. , 2002, Trends in microbiology.

[13]  R. Gallo,et al.  Cathelicidins, essential gene-encoded mammalian antibiotics , 2002, Journal of Molecular Medicine.

[14]  Andreas Peschel,et al.  How do bacteria resist human antimicrobial peptides? , 2002, Trends in microbiology.

[15]  Robert E W Hancock,et al.  Cationic peptides: distribution and mechanisms of resistance. , 2002, Current pharmaceutical design.

[16]  M. Zasloff.  Antimicrobial peptides of multicellular organisms , 2002, Nature.

[17]  Takaaki Ohtake,et al.  Innate antimicrobial peptide protects the skin from invasive bacterial infection , 2001, Nature.

[18]  R. Hancock,et al.  Cationic peptides: effectors in innate immunity and novel antimicrobials. , 2001, The Lancet. Infectious diseases.

[19]  V. Nizet,et al.  Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. , 2001, The Journal of investigative dermatology.

[20]  Michael Otto,et al.  Staphylococcus aureus Resistance to Human Defensins and Evasion of Neutrophil Killing via the Novel Virulence Factor Mprf Is Based on Modification of Membrane Lipids with l-Lysine , 2001, The Journal of experimental medicine.

[21]  O. Chertov,et al.  Participation of mammalian defensins and cathelicidins in anti‐microbial immunity: receptors and activities of human defensins and cathelicidin (LL‐37) , 2001, Journal of leukocyte biology.

[22]  H. Jörnvall,et al.  The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. , 2000, Blood.

[23]  Robert Bals,et al.  Epithelial antimicrobial peptides in host defense against infection , 2000, Respiratory research.

[24]  S. Salzberg,et al.  Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. , 2000, Science.

[25]  G. H. Gudmundsson,et al.  Neutrophil antibacterial peptides, multifunctional effector molecules in the mammalian immune system. , 1999, Journal of immunological methods.

[26]  Y. Shai,et al.  Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. , 1999, The Biochemical journal.

[27]  M. Vasil,et al.  Pseudomonas aeruginosa fur Overlaps with a Gene Encoding a Novel Outer Membrane Lipoprotein, OmlA , 1999, Journal of bacteriology.

[28]  P. Langford,et al.  Periplasmic Superoxide Dismutase in Meningococcal Pathogenicity , 1998, Infection and Immunity.

[29]  Y. Shai,et al.  Mode of action of linear amphipathic α-helical antimicrobial peptides , 1998 .

[30]  Y. Shai,et al.  Mode of action of linear amphipathic alpha-helical antimicrobial peptides. , 1998, Biopolymers.

[31]  A. Johnsen,et al.  hCAP‐18, a cathelin/pro‐bactenecin‐like protein of human neutrophil specific granules , 1995, FEBS letters.

[32]  B. Schonwetter,et al.  Epithelial antibiotics induced at sites of inflammation , 1995, Science.

[33]  Kay Hofmann,et al.  Tmbase-A database of membrane spanning protein segments , 1993 .

[34]  M. Zasloff,et al.  Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[35]  P. Trieu-Cuot,et al.  Nucleotide sequence of the erythromycin resistance gene of the conjugative transposon Tn1545. , 1990, Nucleic acids research.

[36]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.